Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Mark R. Hake, CFA

REVEALED: Kenvue stock has unusual put option activity after lower q2 sales and ceo firing | Rare Historical Photos

Kenvue, Inc. (KVUE), which manufactures Band-Aid, Listerine, Neutrogena, and Johnson's consumer products, reported disappointing Q2 sales and just announced that its CEO had left. Put options are showing unusually high volume today. 

KVUE is at $21.59 today, well off its highs after releasing disappointing Q1 sales results on May 8. That probably led to the CEO's ouster yesterday. But it could be a value investor's signal to consider buying into KVUE stock.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.